In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. SparkRx is a self-guided therapy program for teens run entirely on ...

SAN FRANCISCO--(BUSINESS WIRE)--Today, Limbix, a prescription digital therapeutic company developing treatments for adolescent mental health disorders, announced it has raised $15 million in Series A2 ...

Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for adolescents with symptoms of depression after reporting positive results in a clinical trial.

Big Health, one of the leading companies producing apps to help treat mental health conditions, on Thursday announced it acquired Limbix, developer of a prescription app for adolescent depression. The ...

Digital therapeutics company Big Health announced it acquired Limbix, a maker of prescription digital therapeutics aimed at treating depression in teens and young adults. Limbix is the creator of ...

SAN FRANCISCO & NASHVILLE, Tenn.--(BUSINESS WIRE)--Limbix, a developer of digital therapeutics focused on adolescent mental health treatment, and BehaVR, LLC, a leading innovator of virtual reality ...

Limbix, maker of a prescription digital therapeutic aimed at treating depression in teens, scooped up $15 million in Series A2 funding. The round was led by GSR Ventures, with participation from ...

One of the most important applications of digital therapeutics is in mental health, and with millions of Americans stuck at home due to the Covid-19 pandemic, that potential use has come to the fore ...

Big Health, a maker of digital therapeutics, announced it was acquiring Limbix, creator of digital therapeutics for adolescents. The acquisition marks Big Health’s first entry into the adolescent ...